Cresud director sells 10,000 shares at $1.10
CRESUD INC (CRESY) reported that director Fernando Adrian Elsztain sold 10,000 Common Shares on August 20, 2026, in a sale classified as an open-market or private transaction.
Rhea-AI Filing Summary
CRESUD INC (CRESY) reported that director Fernando Adrian Elsztain sold 10,000 Common Shares on August 20, 2026, in a sale classified as an open-market or private transaction. The shares were sold at a reported price of USD 1.10 per share, leaving him with 625,736 Common Shares held directly after the transaction.
According to the accompanying note, the USD price reflects the equivalent of ARS 1,733.26 per ordinary share, based on an implied exchange rate of 1,579.23 ARS per 1.00 USD. This rate was derived from the closing price of the company’s American Depositary Shares on the NYSE and the underlying ordinary shares on BYMA, using a ratio of 10 ordinary shares per 1 ADS. The filing does not indicate that the transaction was made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares F1 | 10,000 | $1.10 | $11K |
Footnotes (1)
- F1. The price reported in Column 4 is the U.S. Dollar (USD) equivalent of Argentine Pesos (ARS) 1,733.26 per ordinary share. This equivalent is calculated based on an implied exchange rate of 1,579.23 ARS per 1.00 USD, resulting in a reported price of USD 1.10 per ordinary share. This implied rate is derived from the closing price of the Issuer's American Depositary Shares (ADS) on the NYSE on August 20, 2026, relative to the closing price of the underlying ordinary shares on the Bolsas y Mercados Argentinos (BYMA), adjusting for the ratio of 10 ordinary shares per 1 ADS.
Key Figures
Key Terms
implied exchange rate financial
Bolsas y Mercados Argentinos (BYMA) financial
FAQ
What insider transaction did CRESY disclose in this Form 4?
Was the CRESY insider sale made under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.